Found 5 matching trials
A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
PHASE1Phase Ib/II open label, multicenter study to evaluate the efficacy and safe...
Status
Active Not Recruiting
Location
Zhejiang Cancer Hospital
A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
PHASE3This is a phase 3 study. All subjects arerecurrent or metastatic head and n...
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
A Study of AK112 in Advanced Malignant Tumors
PHASE1Phase Ib/II open label, multicenter study to evaluate the efficacy and safe...
Location
Zhejiang Cancer Hospital
A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer
PHASE2This trial is a Phase II study. The purpose of this study is to evaluate th...
Status
Active Not Recruiting
Location
Hunan Cancer Hospital
Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN
PHASE3This is a randomized, open-label, active-comparator-controlled, multi-regio...
Location
Centre Guillaume Le Conquerant